Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • 100th anniversary
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Medicine
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Reviews
    • Viewpoints
    • Top read articles
  • Clinical Medicine

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Clinical Medicine
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Reviews
  • Viewpoints
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Retraction Free access | 10.1172/JCI87345

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco, and Massimo Santoro

Find articles by Melillo, R. in: JCI | PubMed | Google Scholar

Find articles by Castellone, M. in: JCI | PubMed | Google Scholar

Find articles by Guarino, V. in: JCI | PubMed | Google Scholar

Find articles by De Falco, V. in: JCI | PubMed | Google Scholar

Find articles by Cirafici, A. in: JCI | PubMed | Google Scholar

Find articles by Salvatore, G. in: JCI | PubMed | Google Scholar

Find articles by Caiazzo, F. in: JCI | PubMed | Google Scholar

Find articles by Basolo, F. in: JCI | PubMed | Google Scholar

Find articles by Giannini, R. in: JCI | PubMed | Google Scholar

Find articles by Kruhoffer, M. in: JCI | PubMed | Google Scholar

Find articles by Orntoft, T. in: JCI | PubMed | Google Scholar

Find articles by Fusco, A. in: JCI | PubMed | Google Scholar

Find articles by Santoro, M. in: JCI | PubMed | Google Scholar

Published April 1, 2016 - More info

Published in Volume 126, Issue 4 on April 1, 2016
J Clin Invest. 2016;126(4):1603–1603. https://doi.org/10.1172/JCI87345.
Copyright © 2016, American Society for Clinical Investigation
Published April 1, 2016 - Version history
View PDF

Related article:

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Rosa Marina Melillo, … , Alfredo Fusco, Massimo Santoro
Rosa Marina Melillo, … , Alfredo Fusco, Massimo Santoro
Retraction

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

  • Text
  • PDF
Abstract

Authors

Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco, Massimo Santoro

×

Original citation: J Clin Invest. 2005;115(4):1068–1081. doi:10.1172/JCI22758.

Citation for this retraction: J Clin Invest. 2016;126(4):1603. doi:10.1172/JCI87345.

At the request of the corresponding author, the JCI is retracting this manuscript. The corresponding author recently notified the JCI that multiple microscopy images in Figure 2B were previously published and were used to represent different samples in another publication by the corresponding author’s group (1). The authors have stated that experimental data produced ad hoc are consistent with those in the original publication; however, the paper is being retracted due to data duplication and misrepresentation in the original publication.

Footnotes

See the related article beginning on page 1068.

References
  1. Melillo RM, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol. 2004;165(2):511–521.
    View this article via: PubMed CrossRef Google Scholar
Version history
  • Version 1 (April 1, 2016): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts